In June, the FDA extended the public comment period for the 503B Bulks List proposal to the end of July
Evidence, Safety & Real Alternatives (2026) No
Another important consideration is muscle loss
While these agents are still under investigation, they underscore a fundamental shift: obesity pharmacotherapy is moving beyond single-hormone mimicry toward integrated, multi-system approaches that more closely mimic the bodys complex physiology of weight regulation.
Correct? Dr
But since the advent of commercial drug manufacturing and the FDAs creation of a strict regulatory process for bringing safe, effective medications to market, compounding has been legally relegated to two scenarios, Robin Feldman, JD, a professor at the University of California College of the Law in San Francisco and an expert on pharmaceutical law, tells SELF